Maternal Circulating Angiogenic Biomarkers for Predicting Fetal Growth Restriction and Small-for-Gestational-Age Birth Without Preeclampsia
International Journal of Molecular Sciences · 15.10.2026 · 27 (20) · 9155
DOI: 10.3390/ijms27209155 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.10.2026. Verfasst von Min-A Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Biomarkers, Infant, Small for Gestational Age, Placenta Growth Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yonsei University College of Medicine, National Research Foundation of Korea.
Abstract (Originalsprache)
Maternal circulating angiogenic factors are established biomarkers in preeclampsia, but their early profiles in fetal growth impairment without preeclampsia remain unclear. We quantitatively synthesized data from observational studies measuring maternal serum placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), or their ratio before 29 weeks and before clinical recognition of growth impairment in singleton pregnancies without preeclampsia, subsequently classified as fetal growth restriction (FGR), small for gestational age (SGA), or unaffected. PubMed, Embase, and the Cochrane Library were searched through April 2026; 22 studies were included. In random-effects meta-analysis, PlGF was lower in affected pregnancies (standardized mean difference [SMD] −0.38; 95% CI −0.63 to −0.13; I2 = 92.0%; 19 studies), whereas sFlt-1 did not differ (SMD 0.03; 95% CI −0.27 to 0.34; I2 = 79.5%; 12 studies) and the ratio was higher in the primary analysis (SMD 0.39; 95% CI 0.08 to 0.70; I2 = 80.0%; seven studies). This pattern suggests that the ratio signal was influenced largely by lower PlGF. Bivariate analysis of five PlGF accuracy studies yielded a summary sensitivity of 0.29 and specificity of 0.86. Despite substantial heterogeneity, reduced PlGF was the most consistent early angiogenic feature in pregnancies subsequently classified as FGR/SGA without preeclampsia. Its low sensitivity does not support its use as a stand-alone screening test, but these findings warrant further evaluation of PlGF within multimarker prediction models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea.
- Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul 06273, Republic of Korea.
ORCID-Profile: Min-A Kim, Hye Sun Lee, Ah-Young Choi
Förderung
- Yonsei University College of Medicine
- National Research Foundation of Korea
Zitieren
APA
Kim, M. A., Lee, E., Lee, H. S., & Choi, A. Y. (2026). Maternal Circulating Angiogenic Biomarkers for Predicting Fetal Growth Restriction and Small-for-Gestational-Age Birth Without Preeclampsia. International Journal of Molecular Sciences, 27(20), 9155. https://doi.org/10.3390/ijms27209155
Vancouver
Kim MA, Lee E, Lee HS, Choi AY. Maternal Circulating Angiogenic Biomarkers for Predicting Fetal Growth Restriction and Small-for-Gestational-Age Birth Without Preeclampsia. International Journal of Molecular Sciences. 2026;27(20):9155. doi:10.3390/ijms27209155
BibTeX
@article{Kim2026,
author = {Kim, Min-A and Lee, Eunju and Lee, Hye Sun and Choi, Ah-Young},
title = {Maternal Circulating Angiogenic Biomarkers for Predicting Fetal Growth Restriction and Small-for-Gestational-Age Birth Without Preeclampsia},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {20},
pages = {9155},
doi = {10.3390/ijms27209155}
}
EUVIMED